Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TROP2 expression and therapeutic targeting in uterine carcinosarcoma.
Moufarrij S, Dopeso H, Brown DN, Green H, Gill K, Tengelin J, Brodeur MN, Zammarrelli WA 3rd, Varice N, Wu M, Jungbluth A, Zhu Y, Chen X, Da Cruz Paula A, Basili T, de Stanchina E, Abu-Rustum NR, Aghajanian C, Ellenson LH, Chui MH, Weigelt B. Moufarrij S, et al. Gynecol Oncol. 2025 Jun;197:129-138. doi: 10.1016/j.ygyno.2025.04.590. Epub 2025 May 8. Gynecol Oncol. 2025. PMID: 40344963
APOBEC3 mutagenesis drives therapy resistance in breast cancer.
Gupta A, Gazzo A, Selenica P, Safonov A, Pareja F, da Silva EM, Brown DN, Shao H, Zhu Y, Patel J, Blanco-Heredia J, Stefanovska B, Carpenter MA, Chen Y, Vegas I, Pei X, Frosina D, Jungbluth AA, Ladanyi M, Curigliano G, Weigelt B, Riaz N, Powell SN, Razavi P, Harris RS, Reis-Filho JS, Marra A, Chandarlapaty S. Gupta A, et al. Among authors: jungbluth aa. Nat Genet. 2025 Jun;57(6):1452-1462. doi: 10.1038/s41588-025-02187-1. Epub 2025 May 16. Nat Genet. 2025. PMID: 40379787 Free PMC article.
Prognostic significance of estrogen receptor expression and estrogen signaling in endometrial carcinomas of no specific molecular profile: A comprehensive molecular and pathologic analysis.
Lam C, Zhou Q, Aghajanian C, Abu-Rustum NR, Mueller JJ, Ellenson LH, Green AK, Weigelt B, Jungbluth AA, Momeni-Boroujeni A. Lam C, et al. Among authors: jungbluth aa. Gynecol Oncol. 2025 May 24;198:59-65. doi: 10.1016/j.ygyno.2025.05.015. Online ahead of print. Gynecol Oncol. 2025. PMID: 40414144
Programmed death ligand-1 PET imaging in patients with melanoma: a pilot study.
Pandit-Taskar N, Mauguen A, Frosina D, Jungbluth A, Busam KJ, Lyashchenko S, Schwartz J, Momtaz P, Warner AB, Smithy JW, Shoushtari AN, Callahan MK, Chapman PB, Postow MA. Pandit-Taskar N, et al. Melanoma Res. 2025 Jun 25. doi: 10.1097/CMR.0000000000001050. Online ahead of print. Melanoma Res. 2025. PMID: 40557547
GPA33-pretargeted radioimmunotherapy with mono- and bivalent DOTA-based Lu-177-labeled radiohaptens in a mouse orthotopic liver xenograft model of metastatic human colorectal cancer.
Le Roux AB, Fung EK, Lee SG, Monette S, Xu H, Guo HF, Yang G, Ouerfelli O, Jungbluth A, Schöder H, Larson SM, Cheung NV, Cheal SM, Veach DR. Le Roux AB, et al. Theranostics. 2025 May 25;15(13):6274-6289. doi: 10.7150/thno.107209. eCollection 2025. Theranostics. 2025. PMID: 40521192 Free PMC article.
231 results